Medical News

RSS

Former NIH chief Varmus to head National Cancer Institute

The New York Times: "Dr. Harold E. Varmus, a Nobel Prize-winning biologist and former director of the National Institutes of Health, will become director of the National Cancer Institute, the White House announced Monday. President Obama selected Dr. Varmus, who is now president of Memorial Sloan-Kettering Cancer Center in New York, after a lengthy search. Dr. Varmus is expected to shake up the much-criticized federal cancer program" (Pear, 5/17).

19 May 2010

GHESKIO awarded prestigious 2010 Gates Award for Global Health

GHESKIO, an institution in Haiti founded nearly three decades ago to fight a mysterious killer disease later identified as AIDS, has been awarded the prestigious 2010 Gates Award for Global Health for its years of groundbreaking clinical service, research and training to effectively treat and prevent the spread of the HIV/AIDS and other related illnesses.

19 May 2010

Molecular Devices' foundational planar patch-clamp patent upheld by European Patent Office

Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.

19 May 2010

Massachusetts insurers blame caps on rate increases for large losses

Four of Massachusetts largest health insurers posted first-quarter losses with three blaming Gov. Deval Patrick's rate increase caps for the bulk of the financial hit that totaled more than $150 million.

19 May 2010

Insuring your health: New health law throws lifeline to 'uninsurables'

In this new KHN consumer column, produced in collaboration with The Washington Post, Michelle Andrews writes about high-risk pools: "If you're sick - or have ever been sick - and can't get insurance, the new health-care law promises fast relief: access to guaranteed coverage through a special federally funded insurance program starting in July.

19 May 2010

Aprea to present poster on phase I/II clinical trial of APR-246 anticancer compound at ASCO Meeting

Among more than 5000 poster abstracts, Aprea AB has been selected to present a poster at the annual American Society of Clinical Oncology (ASCO) Meeting in Chicago. The presentation will describe the scientific rational and design of the ongoing phase I/II clinical trial with Aprea's drug candidate APR-246.

19 May 2010

NAC therapy shows promise for patients with mild IPF

A new therapy shows promise for patients with mild idiopathic pulmonary fibrosis. According to researchers in Japan, inhaled N-acetylcysteine monotherapy preserves more lung function in some idiopathic pulmonary fibrosis patients than no therapy.

19 May 2010

Market for telehealth and home health monitoring to grow up to $7.7 billion by 2012: Survey

AMERICAN TELEMEDICINE ASSOCIATION ANNUAL MEETING - Health care delivery in the United States will undergo dramatic changes over the next 10 years through the adoption of telehealth, according to a national survey of health care and information technology professionals sponsored by Intel Corporation.

19 May 2010

Oncolytics announces publication of Phase Ia/Ib U.K. clinical trial results of REOLYSIN for cancer

Oncolytics Biotech Inc. announced today that a paper entitled "Two-Stage Phase I Dose-Escalation Study of Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers," has been published in the online version of the journal Clinical Cancer Research.

19 May 2010

Causes and treatment options of mental disorders need to be reassessed: JAMA commentary

It is time to reassess mental disorders, recognizing that these are disorders of brain circuits likely caused by development processes, according to a commentary in the May 19 issue of JAMA, a theme issue on mental health.

19 May 2010

Minn. budget deal postpones key Medicaid decision

Minnesota's Democratic-controlled legislature ended a budget standoff Monday with Republican Gov. Tim Pawlenty that focused on an impasse over Medicaid policy, The Wall Street Journal reports.

19 May 2010

Cincinnati Children's Hospital Medical Center launches REGID

A new nationwide registry will allow researchers to conduct larger, more effective studies of often misdiagnosed disorders that affect thousands of children in the United States.

19 May 2010

Hospital tries 'speed dating' to attract doctors, patients

Kaiser Health News staff writer Jenny Gold, working in collaboration with NPR, reports on a new way for patients to find physicians: "It's Tuesday afternoon, and time for speed dating to begin - at a local hospital near Dallas.

19 May 2010

Lentigen receives NIH STTR grant for Hunter syndrome lentiviral gene therapy

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business technology transfer (STTR) grant for a program on "Lentiviral Gene Therapy for Mucopolysaccharidosis."

19 May 2010

FDA approves Conceptus' ESS305 Essure procedure for increased bilateral placement rate of 96.9%

Conceptus Inc., developer of the Essure(R) procedure, the first and proven non-surgical permanent birth control method, announced today that the third generation (ESS305) of the Essure procedure has received FDA-approval for an improved bilateral placement rate of 96.9%. Improvement in the hysteroscopic time of 9 minutes is an additional benefit.

19 May 2010

PCMA releases statement on AARP's report on price increase in brand name prescriptions

The Pharmaceutical Care Management Association released the following statement on a new report from AARP that found that the price of brand name prescriptions most widely used by Medicare beneficiaries increased by 9.7 percent in the 12 months ending with March 2010 and was much higher than the rate of increase observed during any of the prior eight years

19 May 2010

Health law already affecting consumers, insurers, brokers

The New York Times profiles one man's current insurance dilemma, one which is not likely to happen in the future under the new health law: "Ever since Thomas DeLorenzo was accepted to three law schools outside his home state of California, he has spent entire days on the phone with health insurers in other states, compiling information that he enters on a giant spreadsheet." DeLorenzo, "who has AIDS, will lose his health coverage in California if he moves out of state.

19 May 2010

States combat health costs, workforce and safety issues

"The Massachusetts Senate is weighing a bill aimed at curbing soaring health care costs for individuals and small businesses. Senate President Therese Murray says the bill will ease market instability, smooth out annual fluctuations in premiums and require insurers [to] offer affordable small business plans" (5/18).

19 May 2010

Researchers discover biological pathway signature of ccRCC

By examining expression of every human gene in clear cell renal cell carcinoma compared to normal kidney cells, researchers at Mayo Clinic's campus in Florida have discovered gene signatures they say explain much of the biology of this common and difficult-to-treat kidney cancer.

19 May 2010

RegeneRx Biopharmaceuticals prices underwritten public offering at $0.41 per unit

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration in cardiovascular diseases, central nervous system injuries, ophthalmic indications and dermal wounds, announced the pricing of its previously announced underwritten public offering of 11,500,000 units of its securities at a public offering price of $0.41 per unit.

19 May 2010

Medical News

Former NIH chief Varmus to head National Cancer Institute

GHESKIO awarded prestigious 2010 Gates Award for Global Health

Molecular Devices' foundational planar patch-clamp patent upheld by European Patent Office

Massachusetts insurers blame caps on rate increases for large losses

Insuring your health: New health law throws lifeline to 'uninsurables'

Aprea to present poster on phase I/II clinical trial of APR-246 anticancer compound at ASCO Meeting

NAC therapy shows promise for patients with mild IPF

Market for telehealth and home health monitoring to grow up to $7.7 billion by 2012: Survey

Oncolytics announces publication of Phase Ia/Ib U.K. clinical trial results of REOLYSIN for cancer

Causes and treatment options of mental disorders need to be reassessed: JAMA commentary

Minn. budget deal postpones key Medicaid decision

Cincinnati Children's Hospital Medical Center launches REGID

Hospital tries 'speed dating' to attract doctors, patients

Lentigen receives NIH STTR grant for Hunter syndrome lentiviral gene therapy

FDA approves Conceptus' ESS305 Essure procedure for increased bilateral placement rate of 96.9%

PCMA releases statement on AARP's report on price increase in brand name prescriptions

Health law already affecting consumers, insurers, brokers

States combat health costs, workforce and safety issues

Researchers discover biological pathway signature of ccRCC

RegeneRx Biopharmaceuticals prices underwritten public offering at $0.41 per unit

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News